“Environmental risk factors associated with juvenile idiopathic arthritis associated uveitis: a systematic review of the literature”
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1869-5760
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
“Environmental risk factors associated with juvenile idiopathic arthritis associated uveitis: a systematic review of the literature” ; volume:11 ; number:1 ; day:24 ; month:5 ; year:2021 ; pages:1-9 ; date:12.2021
Journal of ophthalmic inflammation and infection ; 11, Heft 1 (24.5.2021), 1-9, 12.2021
- Creator
-
Clarke, Sarah L. N.
Mageean, Katie S.
Carlton, Henry
Simonini, Gabriele
Sharp, Gemma C.
Relton, Caroline L.
Ramanan, Athimalaipet V.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12348-021-00247-1
- URN
-
urn:nbn:de:101:1-2021091807311955080729
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Clarke, Sarah L. N.
- Mageean, Katie S.
- Carlton, Henry
- Simonini, Gabriele
- Sharp, Gemma C.
- Relton, Caroline L.
- Ramanan, Athimalaipet V.
- SpringerLink (Online service)
Other Objects (12)
Juvenile idiopathic arthritis-associated uveitis
Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab
Perinatal events and development of juvenile idiopathic arthritis-associated uveitis
Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST—Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial
Knowledge about juvenile idiopathic arthritis-associated uveitis: more frequent reminders are associated with higher patient and family uveitis knowledge
Immunomodulatory treatment and surgical management of idiopathic uveitis and juvenile idiopathic arthritis-associated uveitis in children: a French survey practice
Juvenile idiopathic arthritis-associated uveitis: a retrospective analysis from a centre of South Italy
Uveitis associated with juvenile arthritis: a continued cohort study 40 years after uveitis onset
Juvenile idiopathic arthritis associated with a mutation in GATA3
Cross sectional, qualitative thematic analysis of patient perspectives of disease impact in juvenile idiopathic arthritis-associated uveitis
Frequency of juvenile idiopathic arthritis and associated uveitis in pediatric rheumatology clinics in Turkey: A retrospective study, JUPITER
Reactivation of juvenile idiopathic arthritis associated uveitis with posterior segment manifestations following anti-SARS-CoV-2 vaccination
Juvenile idiopathic arthritis-associated uveitis
Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab
Perinatal events and development of juvenile idiopathic arthritis-associated uveitis
Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST—Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial
Knowledge about juvenile idiopathic arthritis-associated uveitis: more frequent reminders are associated with higher patient and family uveitis knowledge
Immunomodulatory treatment and surgical management of idiopathic uveitis and juvenile idiopathic arthritis-associated uveitis in children: a French survey practice
Juvenile idiopathic arthritis-associated uveitis: a retrospective analysis from a centre of South Italy
Uveitis associated with juvenile arthritis: a continued cohort study 40 years after uveitis onset
Juvenile idiopathic arthritis associated with a mutation in GATA3
Cross sectional, qualitative thematic analysis of patient perspectives of disease impact in juvenile idiopathic arthritis-associated uveitis
Frequency of juvenile idiopathic arthritis and associated uveitis in pediatric rheumatology clinics in Turkey: A retrospective study, JUPITER
Reactivation of juvenile idiopathic arthritis associated uveitis with posterior segment manifestations following anti-SARS-CoV-2 vaccination
Juvenile idiopathic arthritis-associated uveitis
Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab
Perinatal events and development of juvenile idiopathic arthritis-associated uveitis
Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST—Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial
Knowledge about juvenile idiopathic arthritis-associated uveitis: more frequent reminders are associated with higher patient and family uveitis knowledge
Immunomodulatory treatment and surgical management of idiopathic uveitis and juvenile idiopathic arthritis-associated uveitis in children: a French survey practice
Juvenile idiopathic arthritis-associated uveitis: a retrospective analysis from a centre of South Italy
Uveitis associated with juvenile arthritis: a continued cohort study 40 years after uveitis onset
Juvenile idiopathic arthritis associated with a mutation in GATA3
Cross sectional, qualitative thematic analysis of patient perspectives of disease impact in juvenile idiopathic arthritis-associated uveitis
Frequency of juvenile idiopathic arthritis and associated uveitis in pediatric rheumatology clinics in Turkey: A retrospective study, JUPITER